Rana el Kaliouby, CEO & Cofounder, Affectiva
Permanent Carbon Removal, Grid Services and Clean Water Josh Santos, Co-Founder & CEO, Noya Noya: https://www.noya.co/
Noya is working to deliver the high-quality, permanent, carbon removal that the Intergovernmental Panel on Climate Change (IPCC) has identified as necessary in order to limit global warming below 1.5℃. The company’s proprietary direct air capture (DAC) system produces a significant amount of clean water (6 million m3 per year per full-scale facility) and unlocks grid services in addition to high-quality carbon removal credits. The team enjoys strong support from pioneering carbon removal buyers, including Shopify, Watershed, and one of the largest university endowments, as well as leading investors including USV, Collab Fund, EQT, and DNX Ventures.
MIT ILP's Annual Wuxi, China Symposium will be held on January 7, 2019 hosted by MIT and Wuxi City.
Symposium Theme & areas of interest: IoT, Advanced Manufacturing, New Energy, New Materials, Life Science, Blockchain.
Lightning Talk and Exhibitor Opportunity, Organized by MIT Media Lab with contributions from MIT Startup Exchange and Takeda Pharmaceuticals
Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
At our annual MIT Startup Ecosystem Conference, we celebrate innovation and bring together its many contributors: entrepreneurs, corporates, and university researchers, as well as government representatives, investors, and those involved with incubators and accelerators. We will assemble to discuss creating, supporting, and scaling new ventures and how to increase productivity and competitive advantage. Aligned with the emphasis of MIT Startup Exchange, we will focus on the startup-corporate relationship. Topics will include pain points, valleys of death, and strategies to avoid as well as how to overcome the stones found along the way.
As always, this event features executives from some of the most promising startups connected to MIT who will present lightning talks in two fast-paced sessions, each followed by an opportunity to have direct discussions.
Many consider this conference a must-attend for innovators and executives at industry-leading corporations, especially those working in innovation, emerging technology, corporate venture capital, and/or corporate development/strategy.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Early-stage startups are invited to MIT.nano to learn more about the START.nano program and explore how its state-of-the-art laboratories can support their growth.
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
R&D Conference is our biggest conference of the year. We're looking for 10 speakers/exhibitors.